tirzepatide eating disorder and Food Noise: Clinical Evidence and Patient Experiences Tirzepatide for Weight Loss: RR

In a well-designed randomized trial published in Diabetes, Obesity and Metabolism in 2017, John Blundell and colleagues at the University of Leeds gave people with obesity once-weekly semaglutide and tracked not just how much they ate but what they wanted to eat

Haegeli L, Brunner-La Rocca HP, Wenk M, Pfisterer M, Drewe J, Krhenbhl S, et al

This conservative starting point allows assessment of individual response before increasing

Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action

SGLT-2 is extensively expressed throughout the CNS, and c-Fos expression was also observed within 2 hours of administration of SGLT-2is in mice

When dose adjustments occur without monitoring, uncertainty increases and potential risks may go unnoticed